July 14, 2022 —
NIH-funded clinical trial finds that starting with a cheaper drug and switching to a more expensive drug as needed leads to good vision outcomes in diabetic macular edema.
July 13, 2022 —
National data indicate COVID-era treatment expansion was not associated with harms, add evidence to support take-home treatment for opioid use disorder.
